Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
Ioannis MerinopoulosTharusha GunawardenaNatasha CorballisVasiliki TsampasianVassilios S VassiliouSimon EccleshallAlisdair RydingGeorge XydopoulosPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
We have compared the cost-effectiveness of DCB-only angioplasty to DES-angioplasty and showed that the per patient and per lesion results were not different and hence cost should not be implicated in the decision to choose DCB or DES.